115 related articles for article (PubMed ID: 2328789)
1. Late effects on pulmonary function of mantle-field irradiation, chemotherapy or combined modality therapy for Hodgkin's disease.
Jensen BV; Carlsen NL; Groth S; Nissen NI
Eur J Haematol; 1990 Mar; 44(3):165-71. PubMed ID: 2328789
[TBL] [Abstract][Full Text] [Related]
2. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function.
Smith LM; Mendenhall NP; Cicale MJ; Block ER; Carter RL; Million RR
Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):79-84. PubMed ID: 2912958
[TBL] [Abstract][Full Text] [Related]
3. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
Bossi G; Cerveri I; Volpini E; Corsico A; Baio A; Corbella F; Klersy C; Arico M
Ann Oncol; 1997; 8 Suppl 1():19-24. PubMed ID: 9187424
[TBL] [Abstract][Full Text] [Related]
4. Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease.
Jensen BV; Carlsen NL; Nissen NI
Eur Respir J; 1990 Nov; 3(10):1140-5. PubMed ID: 2090476
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary morbidity 10-18 years after irradiation for Hodgkin's disease.
Hassink EA; Souren TS; Boersma LJ; Peerboom PF; Melkert R; van Zandwijk N; Lebesque JV; Bruning PF
Eur J Cancer; 1993; 29A(3):343-7. PubMed ID: 8398331
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
Mefferd JM; Donaldson SS; Link MP
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):679-85. PubMed ID: 2466027
[TBL] [Abstract][Full Text] [Related]
7. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease.
Hirsch A; Vander Els N; Straus DJ; Gomez EG; Leung D; Portlock CS; Yahalom J
J Clin Oncol; 1996 Apr; 14(4):1297-305. PubMed ID: 8648387
[TBL] [Abstract][Full Text] [Related]
8. Serial pulmonary function studies in children treated for newly diagnosed Hodgkin's disease with mantle radiotherapy plus cycles of cyclophosphamide, vincristine, and procarbazine alternating with cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine.
Marina NM; Greenwald CA; Fairclough DL; Thompson EI; Wilimas JA; Mackert PW; Hudson MM; Stokes DC; Bozeman PM
Cancer; 1995 Apr; 75(7):1706-11. PubMed ID: 8826931
[TBL] [Abstract][Full Text] [Related]
9. Lung function impairment in long-term survivors of Hodgkin's disease.
Lund MB; Kongerud J; Nome O; Abrahamsen AF; Bjørtuft O; Forfang K; Boe J
Ann Oncol; 1995 May; 6(5):495-501. PubMed ID: 7545431
[TBL] [Abstract][Full Text] [Related]
10. Late pulmonary toxicity after treatment for Hodgkin's disease.
Villani F; De Maria P; Bonfante V; Viviani S; Laffranchi A; Dell'oca I; Dirusso A; Zanini M
Anticancer Res; 1997; 17(6D):4739-42. PubMed ID: 9494599
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantation.
Gandola L; Siena S; Bregni M; Sverzellati E; Piotti P; Stucchi C; Gianni AM; Lombardi F
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):743-9. PubMed ID: 1976614
[TBL] [Abstract][Full Text] [Related]
12. Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation.
Salloum E; Jillella AP; Nadkarni R; Seropian S; Hu GL; D'Andrea E; Zelterman D; Cooper DL
Cancer; 1998 Apr; 82(8):1506-12. PubMed ID: 9554528
[TBL] [Abstract][Full Text] [Related]
13. Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease.
Watchie J; Coleman CN; Raffin TA; Cox RS; Raubitschek AA; Fahey T; Hoppe RT; Van Kessel A
Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):517-24. PubMed ID: 2435687
[TBL] [Abstract][Full Text] [Related]
14. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
15. [The late cardiac sequelae after mantle-field irradiation. The results in Erlangen's patient caseload].
Friedrich SA; Unverdorben M; Kunkel B; Dunst J
Strahlenther Onkol; 1996 Jan; 172(1):19-24. PubMed ID: 8571182
[TBL] [Abstract][Full Text] [Related]
16. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
[TBL] [Abstract][Full Text] [Related]
17. Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
Valagussa P; Santoro A; Bonadonna G
Ann Oncol; 1992 Sep; 3 Suppl 4():111-5. PubMed ID: 1450071
[TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary function in long-term survivors of childhood Hodgkin's lymphoma: a pilot study.
Kadota RP; Burgert EO; Driscoll DJ; Evans RG; Gilchrist GS
Mayo Clin Proc; 1988 Apr; 63(4):362-7. PubMed ID: 3352319
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study.
Horning SJ; Adhikari A; Rizk N; Hoppe RT; Olshen RA
J Clin Oncol; 1994 Feb; 12(2):297-305. PubMed ID: 7509383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
